Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Endometrial Cancer
• Fallopian Tube Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• BL-M17D1

Snippet

Sponsor: SystImmune Inc. | Conditions: Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING